You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CVT3146

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stress Test in Detecting Heart Damage in Premenopausal Stage

Completed
  • Anatomic Stage I Breast Cancer AJCC v8
  • +20 more
  • Adenosine
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Mar 25, 2020

Coronary Artery Disease (CAD) Trial in United States (drug, radiation, procedure)

Completed
Has Results
  • Coronary Artery Disease (CAD)
  • Roseville, California
  • +10 more
Nov 21, 2017

Coronary Artery Disease (CAD) Trial in United States (regadenoson, overencapsulated caffeine, technetium)

Completed
Has Results
  • Coronary Artery Disease (CAD)
  • Birmingham, Alabama
  • +24 more
Nov 20, 2017

Coronary Artery Disease (CAD) Trial in Worldwide (Regadenoson, Single photon emission computed tomography (SPECT) myocardial

Completed
Has Results
  • Coronary Artery Disease (CAD)
  • Regadenoson
  • Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI)
  • Mobile, Alabama
  • +68 more
Jan 7, 2016

Healthy Volunteers Trial in Baltimore (Regadenoson, Placebo)

Completed
  • Healthy Volunteers
  • Baltimore, Maryland
    Parexel Early Phase Unit
Aug 28, 2013

Asthma, Coronary Artery Disease, Pulmonary Disease, Chronic Obstructive Trial in United States (Regadenoson, Placebo)

Completed
Has Results
  • Asthma
  • +2 more
  • Montgomery, Alabama
  • +48 more
Sep 12, 2012

Kidney Diseases, Coronary Artery Disease Trial in United States (Regadenoson, Placebo)

Completed
Has Results
  • Kidney Diseases
  • Coronary Artery Disease
  • Anniston, Alabama
  • +40 more
May 11, 2012

Coronary Artery Disease Trial in Palo Alto (Regadenoson, Adenosine)

Completed
  • Coronary Artery Disease
  • Palo Alto, California
    Multiple study locations (see Central Contact); CV Therapeutics,
Nov 24, 2009

Coronary Artery Disease Trial in Palo Alto (Regadenoson, Adenosine)

Completed
  • Coronary Artery Disease
  • Palo Alto, California
    Multiple study locations (see Central Contact); CV Therapeutics,
Nov 24, 2009